These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 1392112

  • 1. Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months.
    van der Steen PH, Boezeman JB, Happle R.
    Dermatology; 1992; 184(3):198-201. PubMed ID: 1392112
    [Abstract] [Full Text] [Related]

  • 2. Topical therapy of alopecia areata with squaric acid dibutylester.
    Case PC, Mitchell AJ, Swanson NA, Vanderveen EE, Ellis CN, Headington JT.
    J Am Acad Dermatol; 1984 Mar; 10(3):447-50. PubMed ID: 6725657
    [Abstract] [Full Text] [Related]

  • 3. Seventeen cases of alopecia areata: combination of SADBE topical immunotherapy with other therapies.
    Morita K, Nakamura M, Nagamachi M, Kishi T, Miyachi Y.
    J Dermatol; 2002 Oct; 29(10):661-4. PubMed ID: 12433000
    [Abstract] [Full Text] [Related]

  • 4. Erythema multiforme-like eruptions: a rare side effect of topical immunotherapy with diphenylcyclopropenone.
    Perret CM, Steijlen PM, Zaun H, Happle R.
    Dermatologica; 1990 Oct; 180(1):5-7. PubMed ID: 2137800
    [Abstract] [Full Text] [Related]

  • 5. Hair Regrowth Outcomes of Contact Immunotherapy for Patients With Alopecia Areata: A Systematic Review and Meta-analysis.
    Lee S, Kim BJ, Lee YB, Lee WS.
    JAMA Dermatol; 2018 Oct 01; 154(10):1145-1151. PubMed ID: 30073292
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of topical immunotherapy with squaric acid dibutylester for alopecia areata in Japanese patients.
    Sakai K, Fukushima S, Mizuhashi S, Jinnin M, Makino T, Inoue Y, Ihn H.
    Allergol Int; 2020 Apr 01; 69(2):274-278. PubMed ID: 31767273
    [Abstract] [Full Text] [Related]

  • 8. Topical immunotherapy with diphenylcyclopropenone of patients with alopecia areata--a large retrospective study on 142 patients with a self-controlled design.
    Ohlmeier MC, Traupe H, Luger TA, Böhm M.
    J Eur Acad Dermatol Venereol; 2012 Apr 01; 26(4):503-7. PubMed ID: 21569118
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Long-term results of topical immunotherapy in children with alopecia totalis or alopecia universalis.
    Tosti A, Guidetti MS, Bardazzi F, Misciali C.
    J Am Acad Dermatol; 1996 Aug 01; 35(2 Pt 1):199-201. PubMed ID: 8708020
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Topical immunotherapy in dermatology.
    Buckley DA, du Vivier AW.
    Int J Clin Pract; 1999 Mar 01; 53(2):130-7. PubMed ID: 10344049
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Diphencyprone immunotherapy alters anti-hair follicle antibody status in patients with alopecia areata.
    Tobin DJ, Gardner SH, Lindsey NJ, Hoffmann R, Happle R, Freyschmidt-Paul P.
    Eur J Dermatol; 2002 Mar 01; 12(4):327-34. PubMed ID: 12095876
    [Abstract] [Full Text] [Related]

  • 15. Efficacy of topical sensitizers in the treatment of alopecia areata.
    Rokhsar CK, Shupack JL, Vafai JJ, Washenik K.
    J Am Acad Dermatol; 1998 Nov 01; 39(5 Pt 1):751-61. PubMed ID: 9810892
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Topical immunotherapy in combination with anthralin in the treatment of refractory alopecia areata.
    Kagami S, Kishi Y, Hino H.
    J Cosmet Dermatol; 2020 Sep 01; 19(9):2411-2414. PubMed ID: 32621407
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.